0 Kommentare
0 Geteilt
445 Ansichten
0 Bewertungen
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
From Patent Expiry to Generic Competition: Analyzing the Immediate and Long-Term Impact on Apixaban Market Pricing and AccessThe Apixaban Market’s current momentum is significantly influenced by its robust adoption within the treatment and prevention of venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE). While initially gaining prominence for stroke prevention in non-valvular atrial fibrillation (NVAF), the therapy's application in VTE management represents a...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
-
Global Health Policy and Coagulation: Analyzing the Apixaban Market Global Outlook for the Next DecadeGlobal health policy is increasingly focused on the prevention of non-communicable diseases, with stroke and heart disease at the top of the priority list. International organizations are working to standardize the treatment of conditions like atrial fibrillation across different countries to ensure a high level of care for all patients. This involves the creation of unified clinical guidelines...0 Kommentare 0 Geteilt 731 Ansichten 0 Bewertungen
-
Managing Anticoagulation in Patients with Chronic Kidney Disease: A Critical Industry SegmentPatients with chronic kidney disease (CKD) present a unique challenge in anticoagulation therapy because many medications are cleared by the kidneys. Use cases for Factor Xa inhibitors in this population require careful dosing adjustments to avoid over-accumulation and the subsequent risk of bleeding. This industry segment is particularly critical as CKD patients often have a high prevalence of...0 Kommentare 0 Geteilt 855 Ansichten 0 Bewertungen